Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine

详细信息    查看全文

• 作者：Zoe M. Weinstein^a ; ^{zoe.weinstein@bmc.org} ; Debbie M. Cheng^b ; Emily Quinn^c ; David Hui^d ; Hyunjoong Kim^d ; Gabriela Gryczynski^a ; Jeffrey H. Samet^a ; ^e
• 关键词：Buprenorphine ; Primary care ; Treatment retention ; Psychoactive medication
• 刊名：Drug and Alcohol Dependence
• 出版年：2017
• 出版时间：1 January 2017
• 年：2017
• 卷：170
• 期：Complete
• 页码：9-16
• 全文大小：461 K
• 卷排序：170

文摘

Psychoactive medication use is common among patients on buprenorphine treatment. Psychoactive medications overall were not associated with 6-month disengagement. Gabapentin, clonidine, and promethazine were not associated with 6-month disengagement.